134 related articles for article (PubMed ID: 38237996)
1. "Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update." S. Ghosh, L. Breitscheidel, N. Lazarevic,
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237996
[No Abstract] [Full Text] [Related]
2. Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update.
Ghosh S; Breitscheidel L; Lazarevic N; Martin A; Hafkin J; Hittel N
Eur Respir J; 2021 May; 57(5):. PubMed ID: 33243846
[TBL] [Abstract][Full Text] [Related]
3. Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.
D'Ambrosio L; Centis R; Tiberi S; Tadolini M; Dalcolmo M; Rendon A; Esposito S; Migliori GB
J Thorac Dis; 2017 Jul; 9(7):2093-2101. PubMed ID: 28840010
[TBL] [Abstract][Full Text] [Related]
4. "European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update." N.R. Bhakta, A. McGowan, K.A. Ramsey,
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 38035697
[No Abstract] [Full Text] [Related]
5. Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.
Garcia-Prats AJ; Frias M; van der Laan L; De Leon A; Gler MT; Schaaf HS; Hesseling AC; Malikaarjun S; Hafkin J
Antimicrob Agents Chemother; 2022 May; 66(5):e0214421. PubMed ID: 35404075
[TBL] [Abstract][Full Text] [Related]
6. "Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline." James D. Chalmers, Megan L. Crichton, Pieter C. Goeminne,
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35948349
[No Abstract] [Full Text] [Related]
7. "Spatial transcriptomics for respiratory research and medicine." S. Curras-Alonso, J. Soulier, T. Walter,
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36822638
[No Abstract] [Full Text] [Related]
8. Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid.
Pecora F; Dal Canto G; Veronese P; Esposito S
Microorganisms; 2021 May; 9(5):. PubMed ID: 34067732
[TBL] [Abstract][Full Text] [Related]
9. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.
Dooley KE; Rosenkranz SL; Conradie F; Moran L; Hafner R; von Groote-Bidlingmaier F; Lama JR; Shenje J; De Los Rios J; Comins K; Morganroth J; Diacon AH; Cramer YS; Donahue K; Maartens G;
Lancet Infect Dis; 2021 Jul; 21(7):975-983. PubMed ID: 33587897
[TBL] [Abstract][Full Text] [Related]
10. Delamanid Resistance: Update and Clinical Management.
Nguyen TVA; Anthony RM; Cao TTH; Bañuls AL; Nguyen VAT; Vu DH; Nguyen NV; Alffenaar JC
Clin Infect Dis; 2020 Dec; 71(12):3252-3259. PubMed ID: 32521000
[TBL] [Abstract][Full Text] [Related]
11. "Normative data for multiple breath washout outcomes in school-aged Caucasian children." Pinelopi Anagnostopoulou, Philipp Latzin, Renee Jensen,
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35981729
[No Abstract] [Full Text] [Related]
12. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek,
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 35680153
[No Abstract] [Full Text] [Related]
13. "SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation." M. Schicht, F. Rausch, S. Finotto,
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237999
[No Abstract] [Full Text] [Related]
14. "Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension." Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico,
Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35484798
[No Abstract] [Full Text] [Related]
15. "Interstitial lung abnormalities are associated with decreased mean telomere length." R.K. Putman, G.T. Axelsson, S.Y. Ash,
Eur Respir J; 2023 Sep; 62(3):. PubMed ID: 37690790
[No Abstract] [Full Text] [Related]
16. Progression and prognostic indicators of bronchial disease in children with sickle cell disease.
Williams SN; Nussbaum E; Yoonessi L; Morphew T; Randhawa I
Lung; 2014 Jun; 192(3):385-93. PubMed ID: 24699774
[TBL] [Abstract][Full Text] [Related]
17. Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.
Yang JS; Kim KJ; Choi H; Lee SH
Ann Lab Med; 2018 Nov; 38(6):563-568. PubMed ID: 30027700
[TBL] [Abstract][Full Text] [Related]
18. "Aberrant anti-viral response of natural killer cells in severe asthma." J. Devulder, C. Chenivesse, V. Ledroit,
Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38548273
[No Abstract] [Full Text] [Related]
19. Delamanid expanded access novel treatment of drug resistant tuberculosis.
Rustomjee R; Zumla A
Infect Drug Resist; 2015; 8():359-66. PubMed ID: 26604805
[TBL] [Abstract][Full Text] [Related]
20. "ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer." E.L. O'Dowd, I. Tietzova, E. Bartlett,
Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38302184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
